These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25959722)

  • 1. Co-administration of deflazacort and doxycycline: a potential pharmacotherapy for Duchenne muscular dystrophy.
    Pereira JA; Marques MJ; Santo Neto H
    Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):788-94. PubMed ID: 25959722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Therapy Deflazacort/Doxycyclyne Is Better Than Deflazacort Monotherapy to Alleviate Cardiomyopathy in Dystrophin-Deficient mdx Mice.
    Pereira JA; Mauricio AF; Marques MJ; Neto HS
    J Cardiovasc Pharmacol Ther; 2017 Sep; 22(5):458-466. PubMed ID: 28793824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy.
    Anderson JE; Weber M; Vargas C
    Cell Transplant; 2000; 9(4):551-64. PubMed ID: 11038071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent and improved functional gain in mdx dystrophic mice after treatment with L-arginine and deflazacort.
    Archer JD; Vargas CC; Anderson JE
    FASEB J; 2006 Apr; 20(6):738-40. PubMed ID: 16464957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin/NF-AT pathway.
    St-Pierre SJ; Chakkalakal JV; Kolodziejczyk SM; Knudson JC; Jasmin BJ; Megeney LA
    FASEB J; 2004 Dec; 18(15):1937-9. PubMed ID: 15456738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxycycline ameliorates the dystrophic phenotype of skeletal and cardiac muscles in mdx mice.
    Pereira JA; Taniguti AP; Matsumura C; Marques MJ; Neto HS
    Muscle Nerve; 2012 Sep; 46(3):400-6. PubMed ID: 22907231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy.
    Dubinin MV; Talanov EY; Tenkov KS; Starinets VS; Belosludtseva NV; Belosludtsev KN
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPA protects against muscle damage in the mdx mouse model of Duchenne muscular dystrophy by promoting a shift from the M1 to M2 macrophage phenotype.
    Carvalho SC; Apolinário LM; Matheus SM; Santo Neto H; Marques MJ
    J Neuroimmunol; 2013 Nov; 264(1-2):41-7. PubMed ID: 24090650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice.
    Fogagnolo Mauricio A; Minatel E; Santo Neto H; Marques MJ
    Clin Nutr; 2013 Aug; 32(4):636-42. PubMed ID: 23218947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the beneficial effects of doxycycline on the dystrophic phenotype of the mdx mouse.
    Pereira JA; Matsumura CY; Minatel E; Marques MJ; Santo Neto H
    Muscle Nerve; 2014 Aug; 50(2):283-6. PubMed ID: 24435758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
    Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
    Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly oral prednisolone improves survival and strength in male mdx mice.
    Keeling RM; Golumbek PT; Streif EM; Connolly AM
    Muscle Nerve; 2007 Jan; 35(1):43-8. PubMed ID: 16969833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deflazacort but not prednisone improves both muscle repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse.
    Anderson JE; McIntosh LM; Poettcker R
    Muscle Nerve; 1996 Dec; 19(12):1576-85. PubMed ID: 8941272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of plasma interleukins as biomarkers for deflazacort and omega-3 based Duchenne muscular dystrophy therapy.
    de Carvalho SC; Matsumura CY; Santo Neto H; Marques MJ
    Cytokine; 2018 Feb; 102():55-61. PubMed ID: 29276972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: a magnetic resonance imaging study.
    Mavrogeni S; Papavasiliou A; Douskou M; Kolovou G; Papadopoulou E; Cokkinos DV
    Eur J Paediatr Neurol; 2009 Jan; 13(1):34-40. PubMed ID: 18406648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
    Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J
    J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deflazacort treatment of Duchenne muscular dystrophy.
    Biggar WD; Gingras M; Fehlings DL; Harris VA; Steele CA
    J Pediatr; 2001 Jan; 138(1):45-50. PubMed ID: 11148511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long-term treatment with taurine prevents cardiac dysfunction in mdx mice.
    Mele A; Mantuano P; De Bellis M; Rana F; Sanarica F; Conte E; Morgese MG; Bove M; Rolland JF; Capogrosso RF; Pierno S; Camerino GM; Trabace L; De Luca A
    Transl Res; 2019 Feb; 204():82-99. PubMed ID: 30347179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Therapy With Omega-3 Ameliorates Myonecrosis and Benefits Skeletal Muscle Regeneration in Mdx Mice.
    Apolinário LM; De Carvalho SC; Santo Neto H; Marques MJ
    Anat Rec (Hoboken); 2015 Sep; 298(9):1589-96. PubMed ID: 26011009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols.
    Biggar WD; Politano L; Harris VA; Passamano L; Vajsar J; Alman B; Palladino A; Comi LI; Nigro G
    Neuromuscul Disord; 2004 Sep; 14(8-9):476-82. PubMed ID: 15336688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.